News
The FTC alleges anticompetitive and unfair rebating practices that artificially inflate the list price of insulin.
During Theodorescu's tenure, Cedars-Sinai Cancer doubled its NIH funding and expanded the scope of its research.
Sponsors say a pathway is important because many cancers currently lack an effective screening option.
The FTC maintains that PBMs systematically prefer high list price insulin products with high rebates and fees over low list products.
At the center of the project is a new, flagship campus in Emeryville that will offer outpatient services and hospital-based clinics.
A lack of revenue limits practices' capacity to provide high-quality primary care, report says.
HHS officials reportedly indefinitely postponed the CDC's Advisory Committee of Immunization Practices.
Virtell most recently led Prudential Financial's launch of supplemental health products.
CenterWell and Conviva expect to add 20 to 30 new centers this year and will expand into new metro areas.
While President Trump has vowed not to touch Medicaid or Medicare, a vote is expected next week that would likely cut Medicaid.